Zealand Pharma stock suffered its two worst days on record. Here's what's next for the weight loss drugmaker
--------------------------------------------------------------------
Source: CNBC
Published: 2026-06-19 15:00 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Economy & Finance, Financial Markets, Drugs, Business & Economy
--------------------------------------------------------------------
Snippet:
Shares of Danish biotech Zealand Pharma recently plunged after detailed data on its weight loss drug survodutide showed far higher patient dropout rates than leading treatments, prompting analysts to slash peak sales forecasts and rethink the company's obesity strategy.
--------------------------------------------------------------------